With-DAC and without-DAC materials are not interchangeable descriptions. The Drug Affinity Complex changes molecular design and expected identity evidence.
What procurement and laboratory teams should review
Write DAC status in the specification
Request sequence or an unambiguous molecular description
Compare theoretical and observed mass for the correct form
Prevent shortened labels from obscuring identity
Define the molecular form before comparing offers
Sequence alone may not fully define a peptide material. Termini, modifications, disulfide pattern, counterion, hydration state and presentation can affect molecular-weight calculations, analytical reporting, solubility and handling.
- Record sequence, termini and every modification explicitly.
- State the requested salt or counterion form.
- Treat solubility and stability as material- and condition-specific.
Questions to resolve before quotation or release
- Does the document state DAC status?
- How is Mod GRF terminology defined?
- Which mass and identity method apply?
Resolve variant naming before quotation so label, COA and molecule align.
Source material and further reading
This guide is informed by the following primary guidance and established technical resources. Always confirm the current version and its applicability to your material and jurisdiction.
HK PEPTIDES materials are supplied for laboratory research and documentation workflows only. They are not intended for human consumption, diagnostic use, therapeutic use, veterinary use or clinical application.